Tissue re-biopsy appears now irreplaceable for detecting histologic transformation; furthermore, a ctDNA analysis could suggest a neuroendocrine transversion when it shows an increased EGFR muation AF, especially if together with typical SCLC-associated genetic alterations (Table 1 and Table 2), in patients with aggressive progression. This evidence concerns the gene EGFR and atrial fibrillation.